Profile data is unavailable for this security.
About the company
Baxter International Inc., through its subsidiaries, provides a portfolio of essential healthcare products. The Company’s Medical Products and Therapies segment includes sales of sterile IV solutions, infusion systems, administration sets, parenteral nutrition therapies and surgical hemostat, sealant and adhesion prevention products. Its Healthcare Systems and Technologies segment includes connected care solutions and collaboration tools, including smart bed systems, patient monitoring systems and diagnostic technologies, respiratory health devices and advanced equipment for the surgical space, including surgical video technologies and precision positioning devices. Its Pharmaceuticals segment includes specialty injectable pharmaceuticals, inhaled anesthesia and drug compounding. Its Kidney Care segment includes chronic and acute dialysis therapies and services, including peritoneal dialysis, hemodialysis, continuous renal replacement therapies (CRRT) and other organ support therapies.
- Revenue in USD (TTM)11.77bn
- Net income in USD225.00m
- Incorporated1931
- Employees60.00k
- LocationBaxter International Inc1 Baxter Parkway,DEERFIELD 60015United StatesUSA
- Phone+1 (847) 948-2000
- Fax+1 (302) 655-5049
- Websitehttps://www.baxter.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Solventum Corp | 8.22bn | 720.00m | 12.23bn | 22.01k | 17.01 | 3.83 | 9.68 | 1.49 | 4.16 | 4.16 | 47.45 | 18.48 | 0.5831 | 3.93 | 7.19 | 373,290.30 | 5.11 | -- | 6.03 | -- | 56.38 | -- | 8.76 | -- | 0.8268 | 5.02 | 0.7176 | -- | 0.8241 | -- | 0.2234 | -- | -- | -- |
| Globus Medical Inc | 2.48bn | 91.51m | 13.44bn | 5.00k | 127.66 | 2.83 | 38.41 | 5.42 | 0.6636 | 0.6636 | 18.08 | 29.94 | 0.4747 | 1.28 | 4.58 | 495,719.20 | 1.75 | 6.90 | 1.99 | 7.45 | 58.14 | 71.73 | 3.69 | 14.05 | 1.64 | -- | 0.0974 | 0.00 | 53.34 | 17.08 | -35.39 | -4.72 | 5.57 | -- |
| Revvity Inc | 2.72bn | 258.26m | 13.63bn | 11.50k | 53.48 | 1.73 | 19.86 | 5.01 | 2.09 | 2.06 | 22.06 | 64.88 | 0.2078 | 2.89 | 4.37 | 236,657.00 | 1.97 | 4.76 | 2.15 | 5.39 | 55.44 | 57.19 | 9.49 | 15.34 | 2.97 | 11.96 | 0.2869 | 6.52 | -16.95 | -0.1982 | -64.99 | -5.28 | -2.69 | 0.00 |
| Avantor Inc | 6.82bn | 309.60m | 14.14bn | 14.50k | 45.73 | 2.55 | 19.79 | 2.07 | 0.4544 | 0.4544 | 10.01 | 8.16 | 0.532 | 5.56 | 6.09 | 470,331.00 | 2.42 | 2.97 | 2.75 | 3.35 | 33.53 | 33.44 | 4.54 | 5.06 | 1.06 | 3.29 | 0.4698 | 0.00 | -7.26 | 3.51 | -51.52 | -- | 31.17 | -- |
| Align Technology, Inc. | 3.96bn | 441.57m | 16.86bn | 21.61k | 38.50 | 4.28 | 28.96 | 4.26 | 5.87 | 5.87 | 52.63 | 52.76 | 0.6245 | 4.32 | 4.14 | 183,272.50 | 6.96 | 16.34 | 10.39 | 24.14 | 69.98 | 71.72 | 11.15 | 23.16 | 1.14 | -- | 0.00 | 0.00 | 3.42 | 14.45 | 23.09 | 2.15 | -4.46 | -- |
| Baxter International Inc | 11.77bn | 225.00m | 16.94bn | 60.00k | 75.13 | 2.15 | 12.92 | 1.44 | 0.442 | 0.214 | 23.10 | 15.42 | 0.4105 | 2.91 | 5.42 | 196,133.30 | 0.8198 | 0.1942 | 1.05 | 0.2333 | 38.43 | 38.20 | 2.00 | 0.3674 | 1.09 | 3.81 | 0.6196 | 1,398.94 | 2.12 | 5.94 | 97.15 | -- | 0.982 | 9.71 |
| Hologic Inc | 4.03bn | 789.50m | 18.34bn | 6.99k | 23.78 | 3.58 | 16.70 | 4.55 | 3.32 | 3.32 | 16.97 | 22.09 | 0.4406 | 2.72 | 6.57 | -- | 8.63 | 13.12 | 9.84 | 15.20 | 56.25 | 60.82 | 19.59 | 24.75 | 3.03 | 64.45 | 0.3307 | -- | -0.0025 | 3.66 | 73.14 | -- | 4.30 | -- |
| Insulet Corp | 1.98bn | 420.90m | 18.44bn | 3.00k | 45.71 | 16.50 | 36.96 | 9.30 | 5.75 | 5.75 | 25.96 | 15.94 | 0.7223 | 1.42 | 6.14 | 661,300.00 | 15.32 | 2.71 | 18.56 | 3.14 | 69.36 | 65.81 | 21.22 | 4.28 | 2.80 | 98.71 | 0.5557 | 0.00 | 30.02 | 24.66 | 4,384.78 | 128.77 | -7.63 | -- |
| Cooper Companies Inc | 3.80bn | 359.30m | 20.07bn | 15.00k | 56.13 | 2.53 | 27.27 | 5.28 | 1.80 | 1.80 | 19.02 | 39.80 | 0.3196 | 1.70 | 5.56 | 253,606.70 | 3.02 | 10.06 | 3.29 | 11.34 | 66.36 | 65.54 | 9.45 | 29.00 | 1.18 | 5.46 | 0.2493 | 0.3469 | 8.61 | 7.24 | -23.74 | -3.66 | 15.18 | 0.00 |
| Steris PLC | 5.12bn | 602.62m | 21.16bn | 18.18k | 35.28 | 3.21 | 19.10 | 4.13 | 6.08 | 4.38 | 51.62 | 66.80 | 0.4758 | 3.86 | 5.49 | 281,655.40 | 5.62 | 5.19 | 6.10 | 5.68 | 43.01 | 43.64 | 11.81 | 10.97 | 1.55 | 8.29 | 0.2528 | 36.56 | 13.28 | 13.06 | -1.07 | 12.67 | 13.69 | 8.83 |
| Zimmer Biomet Holdings Inc | 7.60bn | 1.08bn | 21.94bn | 18.00k | 20.99 | 1.78 | 10.66 | 2.89 | 5.25 | 5.25 | 36.87 | 62.00 | 0.3538 | 0.9136 | 5.38 | 421,972.20 | 5.05 | 2.21 | 5.82 | 2.52 | 71.78 | 71.25 | 14.28 | 7.28 | 0.6987 | 7.52 | 0.3425 | 38.90 | 6.55 | -1.40 | 252.86 | -- | 9.44 | 0.00 |
| Waters Corp | 2.91bn | 622.64m | 22.18bn | 7.90k | 35.63 | 13.83 | 27.22 | 7.63 | 10.48 | 10.48 | 48.89 | 27.00 | 0.645 | 2.20 | 4.47 | 367,740.10 | 13.82 | 19.77 | 16.72 | 25.29 | 59.73 | 58.45 | 21.43 | 23.38 | 1.38 | 10.11 | 0.5325 | 0.00 | -0.5229 | 4.09 | -9.26 | 1.53 | 4.72 | -- |
| Illumina Inc | 4.39bn | -1.58bn | 22.23bn | 10.59k | -- | 10.49 | -- | 5.06 | -10.00 | -10.00 | 27.61 | 13.36 | 0.5441 | 2.66 | 6.17 | 414,542.00 | -19.63 | -6.20 | -23.16 | -7.28 | 63.94 | 66.39 | -36.08 | -15.48 | 1.85 | 38.44 | 0.4834 | -- | -1.75 | 6.21 | 73.64 | -- | -7.91 | -- |
| West Pharmaceutical Services Inc. | 2.88bn | 499.60m | 22.93bn | 10.60k | 46.91 | 8.34 | 36.15 | 7.97 | 6.75 | 6.75 | 38.86 | 37.96 | 0.7743 | 4.50 | 5.51 | 271,358.50 | 13.02 | 15.61 | 15.16 | 18.65 | 34.87 | 38.06 | 16.81 | 18.47 | 2.23 | -- | 0.0695 | 10.69 | 2.18 | 11.43 | 2.28 | 23.76 | 28.16 | 6.20 |
Data as of Nov 23 2024. Currency figures normalised to Baxter International Inc's reporting currency: US Dollar USD
48.44%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 30 Sep 2024 | 57.95m | 11.36% |
| Dodge & Coxas of 30 Sep 2024 | 44.60m | 8.74% |
| Pzena Investment Management LLCas of 30 Sep 2024 | 32.22m | 6.32% |
| BlackRock Fund Advisorsas of 30 Sep 2024 | 30.18m | 5.92% |
| SSgA Funds Management, Inc.as of 30 Sep 2024 | 21.78m | 4.27% |
| BlackRock Advisors LLCas of 30 Sep 2024 | 14.77m | 2.90% |
| T. Rowe Price Associates, Inc. (IM)as of 30 Sep 2024 | 14.11m | 2.77% |
| Geode Capital Management LLCas of 30 Sep 2024 | 12.16m | 2.38% |
| Harris Associates LPas of 30 Sep 2024 | 9.78m | 1.92% |
| Columbia Management Investment Advisers LLCas of 30 Sep 2024 | 9.57m | 1.88% |
More ▼
Data from 30 Sep 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
